5-day multi-session intermittent theta burst stimulation over bilateral posterior superior temporal sulci in adults with autism-a pilot study

• Published in: Biomedical Journal 2022-08, Vol.45 (4), p.696-707
• Main Authors: Ni, Hsing-Chang, Lin, Hsiang-Yuan, Chen, Yi-Lung, Hung, June, Wu, Chen-Te, Wu, Yu-Yu, Liang, Hsin-Yi, Chen, Rou-Shayn, Gau, Susan Shur-Fen, Huang, Ying-Zu
• Format: Article
• Language: English
• Subjects: Autism spectrum disorder; Neuropsychological function; Original; Posterior superior temporal sulcus; Repetitive transcranial magnetic stimulation; Theta burst stimulation
• ISSN: 2319-4170; 2320-2890
• DOI: 10.1016/j.bj.2021.07.008

BACKGROUNDTheta burst stimulation (TBS), a patterned repetitive transcranial magnetic stimulation (rTMS) protocol with shorter simulation duration and lower stimulus intensity, could be a better protocol for individuals with autism spectrum disorder (ASD). Our study aimed to explore the impacts of intermittent TBS (iTBS) over the bilateral posterior superior temporal sulcus (pSTS) on intellectually able adults with ASD. METHODSIn this randomized, single-blinded, sham-controlled crossover trial, 13 adults with ASD completed iTBS for 5 consecutive days over the bilateral pSTS and inion (as a sham control) in a 16-weeks interval and in a randomly assigned order. The neuropsychological function was measured with the Wisconsin Card Sorting Test (WCST) for cognitive flexibility while the clinical outcomes were measured with both self-rate and parents-rate Autism Spectrum Quotient (AQ) before and after 5-day iTBS interventions. RESULTSThe results revealed significantly immediate effects of multi-session iTBS over the bilateral pSTS on parent-rate autistic symptoms in adults with ASD. The post-hoc analysis revealed the impacts of multi-session iTBS on cognitive flexibility were affected by baseline social-communicative impairment and baseline cognitive performance. Besides, the impacts of multi-session iTBS on clinical symptoms was affected by the concurrent psychotropic medication use and baseline autistic symptoms. CONCLUSIONSGiven the caveat of the small sample size and discrepancy of multiple informants, this pilot study suggests the therapeutic potential of 5-day multi-session iTBS over the pSTS in adults with ASD. Individual factors modulating the response to rTMS should be explicitly considered in the future trial.